Madrid, Spain

Jose Maria Fiandor Roman

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Madrid, ES (2009 - 2012)
  • Research Triangle Park, NC (US) (2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Jose Maria Fiandor Roman

Introduction

Jose Maria Fiandor Roman is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of four patents to his name, his work has had a considerable impact on therapeutic applications.

Latest Patents

Among his latest patents are the Naphthyridin-2 (1 H)-one compounds, which are useful as antibacterials. These compounds, represented by Formula (I), include various substituents such as substituted phenyl, pyridyl, and thiazolyl, among others. The patents detail their use in therapy, especially in treating tuberculosis, and provide methods for their preparation. Additionally, the compounds and their pharmaceutically acceptable salts or N-oxides are described in pharmaceutical compositions aimed at combating tuberculosis.

Career Highlights

Jose Maria Fiandor Roman is associated with Glaxo Group Limited, where he has been instrumental in advancing research and development in antibacterial therapies. His innovative work has positioned him as a key figure in the pharmaceutical industry, contributing to the fight against infectious diseases.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues such as Alan Joseph Hennessy and Neil David Pearson. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Jose Maria Fiandor Roman's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…